• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.15% Nasdaq Up 0.36%

    More On TSRX

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    Financials

    • Income Statement
    • Balance Sheet
    • Cash Flow

    Trius Therapeutics, Inc. (TSRX)

    -NasdaqGM
    13.63 0.00(0.00%) Sep 11
    Add to Portfolio
    Prev Close:13.63
    Open:N/A
    Bid:N/A
    Ask:N/A
    1y Target Est:14.33
    Beta:1.4
    Next Earnings Date:N/A
    Day's Range:N/A - N/A
    52wk Range:4.41 - 14.17
    Volume:0
    Avg Vol (3m):1,634,750
    Market Cap:N/A
    P/E (ttm):N/A
    EPS (ttm):-1.60
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    • No Headlines available for TSRX at this time.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-13) :N/A
    Quarterly EPS Est (Sep-13) :N/A
    Mean Recommendation*:2.5
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Trius Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of antibiotics for serious infections. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback